US Patent 9527909 Antibodies to tau and uses thereof
Patent 9527909 was granted and assigned to Eli Lilly and Company on December, 2016 by the United States Patent and Trademark Office.
All edits
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Dec, 2023
Golden AI
Edits made to:
Article (+276 characters)
Article
Patent abstract
Monoclonal antibodies to human tau aggregate, compositions comprising such tau antibodies, and methods of using such tau antibodies for the treatment of neurodegenerative diseases including Alzheimer's disease, Progressive Supranuclear Palsy and Pick's disease.
Edits on 29 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alberto Alvarado0
David Driver0
Jirong Lu0
Mansuo Lu Hayashi0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09527909 Antibodies to tau and uses thereof US Patent 9527909 Antibodies to tau and uses thereof
Infobox
Patent Number
09527909
Patent Number
9527909
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09527909 Antibodies to tau and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09527909
Date of patent
December 27, 2016
Patent application number
15046668
Date Filed
February 18, 2016
Patent primary examiner
Find more entities like US Patent 9527909 Antibodies to tau and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
